{'fraction_non_alphanumeric': 0.015068493150684932, 'fraction_numerical': 0.0, 'mean_word_length': 5.469026548672566, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Developing an investigator site budget for clinical trials.

Many community oncology practices become involved in pharmaceutical industry-sponsored clinical trials for two good reasons: to supplement their menu of clinical research projects and to expand treatment options for their patients. Expectations of the site’s investigators are that the sponsor will cover the costs of performing the research. While major research programs in academic centers can sometimes shift costs or cover the costs with philanthropic or other sources of income—making the research project appear to make a profit or at least break even— private practices usually do not have this ability, given the current structure of third-party reimbursement.